RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo

Breast Cancer Research and Treatment

Volumn 123, Issue 2, 2010, Pages 375-386

  Cao, Xi Xi ^a   Xu, Jing Da ^a   Xu, Jia Wen ^a   Liu, Xiao Li ^a   Cheng, Yuan Yuan ^a   Wang, Wen Juan ^a   Li, Qing Quan ^a   Chen, Qi ^a   Xu, Zu De ^a   Liu, Xiu Ping ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Biomarker; Breast carcinoma; Invasion metastasis; Proliferation; RACK1

Indexed keywords

CD147 ANTIGEN; CYCLIN D1; CYCLIN D3; GELATINASE A; PROTEIN KINASE B; RECEPTOR FOR ACTIVATED C KINASE 1;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INVASION; CANCER SURVIVAL; CARCINOMA CELL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR PROMOTION;

ADULT; AGED; ANIMALS; ANTIGENS, CD147; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; CYCLIN D3; FEMALE; GTP-BINDING PROTEINS; HUMANS; KAPLAN-MEIER ESTIMATE; MATRIX METALLOPROTEINASE 2; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CELL SURFACE; RHO-ASSOCIATED KINASES; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77956191630     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0657-x     Document Type: Article

References (41)

1. K McPherson CM Steel JM Dixon 1994 ABC of breast diseases. Breast cancer epidemiology, risk factors and genetics BMJ 309 1003 1006 1:STN:280: DyaK2M%2FjvVWjtw%3D%3D 7950693
2. N Harbeck P Dettmar C Thomssen U Berger K Ulm R Kates H Höfler F Jänicke H Graeff M Schmitt 1999 Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up Br J Cancer 80 419 426 10.1038/sj.bjc.6690373 10.1038/sj.bjc.6690373 1:STN:280:DyaK1MzhsVOltQ%3D%3D 10408848
3. SJ Leevers B Vanhaesebroeck MD Waterfield 1999 Signalling through phosphoinositide 3-kinases: the lipids take centre stage Curr Opin Cell Biol 11 219 225 10.1016/S0955-0674(99)80029-5 10.1016/S0955-0674(99)80029-5 1:CAS:528:DyaK1MXisFWlsbw%3D 10209156
4. I Vivanco CL Sawyers 2002 The phosphatidylinositol 3-kinase AKT pathway in human cancer Nat Rev Cancer 2 489 501 10.1038/nrc839 10.1038/nrc839 1:CAS:528:DC%2BD38XkvFKltLs%3D 12094235
5. Y Samuels Z Wang A Bardelli N Silliman J Ptak S Szabo H Yan A Gazdar SM Powell GJ Riggins JK Willson S Markowitz KW Kinzler B Vogelstein VE Velculescu 2004 High frequency of mutations of the PIK3CA gene in human cancers Science 304 554 10.1126/science.1096502 1:CAS:528:DC%2BD2cXjsVGmsbk%3D 15016963
6. KE Bachman P Argani Y Samuels N Silliman J Ptak S Szabo H Konishi B Karakas BG Blair C Lin BA Peters VE Velculescu BH Park 2004 The PIK3CA gene is mutated with high frequency in human breast cancers Cancer Biol Ther 3 772 775 10.4161/cbt.3.8.994 1:CAS:528:DC%2BD2MXhslKrtbw%3D 15254419
7. DK Broderick C Di TJ Parrett YR Samuels JM Cummins RE McLendon DW Fults VE Velculescu DD Bigner H Yan 2004 Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas Cancer Res 64 5048 5050 10.1158/0008-5472.CAN-04-1170 1:CAS:528:DC%2BD2cXmtF2mtrk%3D 15289301
8. IG Campbell SE Russell DY Choong KG Montgomery ML Ciavarella CS Hooi BE Cristiano RB Pearson WA Phillips 2004 Mutation of the PIK3CA gene in ovarian and breast cancer Cancer Res 64 7678 7681 10.1158/0008-5472.CAN-04-2933 1:CAS:528:DC%2BD2cXptFemtbk%3D 15520168
9. JJ Zhao OV Gjoerup RR Subramanian Y Cheng W Chen TM Roberts WC Hahn 2003 Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase Cancer Cell 3 483 495 10.1016/S1535-6108(03)00088- 6 1:CAS:528:DC%2BD3sXktlyiu70%3D 12781366
10. X Mao CK Kikani RA Riojas P Langlais L Wang FJ Ramos Q Fang CY Christ-Roberts JY Hong RY Kim F Liu LQ Dong 2006 APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function Nat Cell Biol 8 516 523 10.1038/ncb1404 10.1038/ncb1404 1:CAS:528:DC%2BD28XksVGnurY%3D 16622416
11. D Ron CH Chen J Caldwell L Jamieson E Orr D Mochly-Rosen 1994 Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins Proc Natl Acad Sci USA 91 839 843 10.1073/pnas.91.3.839 1:CAS:528:DyaK2cXitFSqurw%3D 8302854
12. H Berns R Humar B Hengerer FN Kiefer EJ Battegay 2000 RACK1 is up-regulated in angiogenesis and human carcinomas FASEB J 14 2549 2558 10.1096/fj.99-1038com 1:CAS:528:DC%2BD3MXht1SntLk%3D 11099474
13. L Hunakova O Sedlakova D Cholujova P Gronesova J Duraj J Sedlak 2009 Modulation of markers associated with aggressive phenotype in MDA-MB-231 breast carcinoma cells by sulforaphane Neoplasma 56 548 556 10.4149/neo-2009-06-548 10.4149/neo-2009-06-548 1:CAS:528:DC%2BD1MXht12hu7zE 19728765
14. D Bartusik B Tomanek E Lattová H Perreault G Fallone 2010 Combined treatment of human MCF-7 breast carcinoma with antibody, cationic lipid and hyaluronic acid using ex vivo assays J Pharm Biomed Anal 51 192 201 10.1016/j.jpba.2009.07.032 10.1016/j.jpba.2009.07.032 1:CAS:528: DC%2BD1MXhtFyqu7jL 19709839
15. HJ Han J Russo Y Kohwi T Kohwi-Shigematsu 2008 SATB1 reprogrammes gene expression to promote breast tumor growth and metastasis Nature 452 187 193 10.1038/nature06781 10.1038/nature06781 1:CAS:528:DC%2BD1cXjt1Gnurg%3D 18337816
16. MD Martin LM Matrisian 2007 The other side of MMPs: protective roles in tumor progression Cancer Metastasis Rev 26 717 724 10.1007/s10555-007-9089-4 10.1007/s10555-007-9089-4 1:CAS:528:DC%2BD2sXht1yktLbK 17717634
17. K Okano HW Schnaper K Bomsztyk T Hayashida 2006 RACK1 binds to Smad3 to modulate transforming growth actor-beta1-stimulated alpha2(I) collagen transcription in renal tubular epithelial cells J Biol Chem 281 26196 26204 10.1074/jbc.M606710200 10.1074/jbc.M606710200 1:CAS:528:DC%2BD28XovFyqsL4%3D 16849317
18. L Hu F Lu Y Wang Y Liu D Liu Z Jiang C Wan B Zhu L Gan Y Wang Z Wang 2006 RACK1, a novel hPER1-interacting protein J Mol Neurosci 1 55 63 10.1385/JMN:29:1:55
19. A Besson TL Wilson VW Yong 2002 The anchoring protein RACK1 links protein kinase Cεto integrin β chains: requirements for adhesion and motility J Biol Chem 277 22073 22084 10.1074/jbc.M111644200 10.1074/jbc.M111644200 1:CAS:528:DC%2BD38Xksl2jtrY%3D 11934885
20. MR Steele A McCahill DS Thompson C MacKenzie NW Isaacs MD Houslay GB Bolger 2001 Identification of a surface on the β-propeller protein RACK1 that interacts with the cAMP-specific phosphodiesterase PDE4D5 Cell Signal 13 507 513 10.1016/S0898-6568(01)00167-X 10.1016/S0898-6568(01)00167-X 1:CAS:528:DC%2BD3MXksVGrsLk%3D 11516626
21. BY Chang M Chiang CA Cartwright 2001 The interaction of Src and RACK1 is enhanced by activation of protein kinase C and tyrosine phosphorylation of RACK1 J Biol Chem 276 20346 20356 10.1074/jbc.M101375200 10.1074/jbc.M101375200 1:CAS:528:DC%2BD3MXktlKnt7w%3D 11279199
22. M Baumann O Gires W Kolch H Mischak R Zeidler D Pich W Hammerschmidt 2000 The PKC targeting protein RACK1 interacts with the Epstein-Barr virus activator protein BZLF1 Eur J Biochem 267 3891 3901 10.1046/j.1432-1327.2000.01430.x 10.1046/j.1432-1327.2000.01430.x 1:CAS:528:DC%2BD3cXksVKgu74%3D 10849009
23. A Gallina F Rossi G Milanesi 2001 Rack1 binds HIV-1 Nef and can act as a Nef-protein kinase C adaptor Virology 283 7 18 10.1006/viro.2001.0855 10.1006/viro.2001.0855 1:CAS:528:DC%2BD3MXivVeht7w%3D 11312657
24. U Hermanto CS Zong W Li LH Wang 2002 RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix Mol Cell Biol 22 2345 2365 10.1128/MCB.22.7.2345-2365.2002 10.1128/MCB.22.7.2345- 2365.2002 1:CAS:528:DC%2BD38Xit1Kit7Y%3D 11884618
25. AB Niculescu III X Chen M Smeets L Hengst C Prives SI Reed 1998 Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication Mol Cell Biol 18 629 643 1:CAS:528:DyaK1cXjtFCqtA%3D%3D 9418909
26. Y Gu CW Turck DO Morgan 1993 Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit Nature 366 707 710 10.1038/366707a0 10.1038/366707a0 1:CAS:528:DyaK2cXnt1ajtQ%3D%3D 8259216
27. JW Harper GR Adami N Wei K Keyomarsi SJ Elledge 1993 The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases Cell 75 805 816 10.1016/0092-8674(93)90499-G 10.1016/0092-8674(93)90499- G 1:CAS:528:DyaK2cXhtVShsLk%3D 8242751
28. K Cai BD Dynlacht 1998 Activity and nature of p21 (WAF1) complexes during the cell cycle Proc Natl Acad Sci USA 95 12254 12259 10.1073/pnas.95.21.12254 1:CAS:528:DyaK1cXmsl2rsLk%3D 9770473
29. VV Ogryzko P Wong BH Howard 1997 WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases Mol Cell Biol 17 4877 4882 1:CAS:528:DyaK2sXkvVCntr0%3D 9234744
30. R Egilmez S Elagoz EA Kanik 2001 Cdk1/P34Cdc2 and P21waf expression in colorectal adenomas and carcinomas J Exp Clin Cancer Res 20 549 552 1:CAS:528:DC%2BD38XhtlehtLw%3D 11876550
31. JP Stein DA Ginsberg GD Grossfeld SJ Chatterjee D Esrig MG Dickinson S Groshen CR Taylor PA Jones DG Skinner RJ Cote 1998 Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer J Natl Cancer Inst 90 1072 1079 10.1093/jnci/90.14.1072 1:CAS:528:DyaK1cXkvVOksL4%3D 9672255
32. MD Westfall DJ Mays JC Sniezek JA Pietenpol 2003 The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations Mol Cell Biol 23 2264 2276 10.1128/MCB.23.7.2264-2276.2003 10.1128/MCB.23.7.2264-2276.2003 1:CAS:528:DC%2BD3sXisFensLk%3D 12640112
33. RK Vadlamudi R Kumar 2003 P21-activated kinases in human cancer Cancer Metastasis Rev 22 385 393 10.1023/A:1023729130497 10.1023/A:1023729130497 1:CAS:528:DC%2BD3sXjslyiu70%3D 12884913
34. R Kumar AE Gururaj CJ Barnes 2006 p21-activated kinases in cancer Nat Rev Cancer 6 459 471 10.1038/nrc1892 1:CAS:528:DC%2BD28XkvVylt70%3D 16723992
35. SH Zigmond 1996 Signal transduction and actin filament organization Curr Opin Cell Biol 8 66 73 10.1016/S0955-0674(96)80050-0 10.1016/S0955-0674(96) 80050-0 1:CAS:528:DyaK28XhtVGqtLc%3D 8791404
36. N Tapon A Hall 1997 Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton Curr Opin Cell Biol 9 86 92 10.1016/S0955-0674(97) 80156-1 10.1016/S0955-0674(97)80156-1 1:CAS:528:DyaK2sXhtFamsLw%3D 9013670
37. J Kroll D Epting K Kern CT Dietz Y Feng HP Hammes T Wieland HG Augustin 2009 Inhibition of Rho-dependent kinases ROCK I/II activates VEGF-driven retinal neovascularization and sprouting angiogenesis Am J Physiol Heart Circ Physiol 296 H893 H899 10.1152/ajpheart.01038.2008 1:CAS:528:DC%2BD1MXjtFGktro%3D 19181962
38. L Yan S Zucker BP Toole 2005 Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression Thromb Haemost 93 199 204 10.1160/TH04-08-0536 1:CAS:528:DC%2BD2MXhs1Kgu7w%3D 15711733
39. T Kanekura X Chen T Kanzaki 2002 Basigin (CD147) is system with an improved hairpin and its significant expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts Int J Cancer 99 520 528 10.1002/ijc.10390 10.1002/ijc.10390 1:CAS:528:DC%2BD38XjsFansL4%3D 11992541
40. P Friedl K Wolf 2008 Tube travel: the role of proteases in individual and collective cancer cell invasion Cancer Res 68 7247 7249 10.1158/0008-5472.CAN- 08-0784 1:CAS:528:DC%2BD1cXhtFWltLnF 18794108
41. Z Wang L Jiang C Huang Z Li L Chen L Gou P Chen A Tong M Tang F Gao J Shen Y Zhang J Bai M Zhou D Miao Q Chen 2008 Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma Mol Cell Proteomics 7 1639 1650 10.1074/mcp.M700520-MCP200 1:CAS:528:DC%2BD1cXhtFantL%2FL 18458027